These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 19326305)
1. The gray zones of privatized imaging. Lau PW; Illes J Am J Bioeth; 2009 Apr; 9(4):21-2. PubMed ID: 19326305 [No Abstract] [Full Text] [Related]
2. Response to open peer commentaries for "Ethical considerations of providing screening tests to individuals when evidence is insufficient to support screening populations". Burger IM; Kass NE Am J Bioeth; 2009 Apr; 9(4):W1-2. PubMed ID: 19326298 [No Abstract] [Full Text] [Related]
3. Professional integrity and screening tests. Doukas DJ Am J Bioeth; 2009 Apr; 9(4):19-21. PubMed ID: 19326304 [No Abstract] [Full Text] [Related]
4. Does direct-to-consumer marketing of medical technologies undermine the physician-patient relationship? Rosenberg L Am J Bioeth; 2009 Apr; 9(4):22-3. PubMed ID: 19326306 [No Abstract] [Full Text] [Related]
5. Rising costs of medical imaging spur debate. Rowan K J Natl Cancer Inst; 2008 Dec; 100(23):1665-7. PubMed ID: 19033570 [No Abstract] [Full Text] [Related]
6. Do routine prenatal ultrasounds validate routine whole-body CT scans? Zivotofsky AZ; Zivotofsky NT Am J Bioeth; 2009 Apr; 9(4):24-5. PubMed ID: 19326307 [No Abstract] [Full Text] [Related]
7. Policy in the light: professional society guidelines begin the ethical conversations about screening. Wilfond BS Am J Bioeth; 2009 Apr; 9(4):17-9. PubMed ID: 19326303 [No Abstract] [Full Text] [Related]
8. Risky business when public plays doctor with open-access MRI. Victoroff MS Manag Care; 2001 Dec; 10(12):50-1. PubMed ID: 11795003 [No Abstract] [Full Text] [Related]
9. Should the ordering of medical imaging examinations be reexamined? Margulis AR; Bhargavan M; Feldman D; Sunshine JH J Am Coll Radiol; 2005 Oct; 2(10):809-11. PubMed ID: 17411937 [No Abstract] [Full Text] [Related]
10. The value of diagnostic medical imaging. Bradley D; Bradley KE N C Med J; 2014; 75(2):121-5. PubMed ID: 24663134 [TBL] [Abstract][Full Text] [Related]
11. The value of information and the ethics of personal-genomic screening. Schwartz PH Am J Bioeth; 2009 Apr; 9(4):26-7. PubMed ID: 19326308 [No Abstract] [Full Text] [Related]
13. ["Check-up" offer to managers: is screening for early recognition of disease being discredited?]. Riemann JF Dtsch Med Wochenschr; 2010 Apr; 135(16):812. PubMed ID: 20391313 [No Abstract] [Full Text] [Related]
15. On patient requests for unproven screening: dim guidance for screening in the dark. Malm H Am J Bioeth; 2009 Apr; 9(4):15-7. PubMed ID: 19326302 [No Abstract] [Full Text] [Related]
18. Screening in the dark: ethical considerations of providing screening tests to individuals when evidence is insufficient to support screening populations. Burger IM; Kass NE Am J Bioeth; 2009 Apr; 9(4):3-14. PubMed ID: 19326299 [TBL] [Abstract][Full Text] [Related]
19. [Diagnostic screening for cancer and coronary heart disease with radiological and nuclear imaging techniques: early diagnosis at any price?]. Weltermann B; Hermann M; Gesenhues S Dtsch Med Wochenschr; 2010 Apr; 135(16):813-8. PubMed ID: 20391314 [TBL] [Abstract][Full Text] [Related]